Go Pro

Conduit Pharmaceuticals (CDTTW) Competitors

$0.01 0.00 (-26.67%)
As of 07/22/2026 02:51 PM Eastern
This is a fair market value price provided by Massive. Learn more.

CDTTW vs. SXTPW, DRTSW, APLMW, BIVIW, and CDIOW

Should you buy Conduit Pharmaceuticals stock or one of its competitors? MarketBeat compares Conduit Pharmaceuticals with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Conduit Pharmaceuticals include 60 Degrees Pharmaceuticals (SXTPW), Alpha Tau Medical (DRTSW), Apollomics (APLMW), BioVie (BIVIW), and Cardio Diagnostics (CDIOW). These companies are all part of the "biotechnology" industry.

How does Conduit Pharmaceuticals compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and Conduit Pharmaceuticals (NASDAQ:CDTTW) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, profitability, institutional ownership, earnings and risk.

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
Conduit Pharmaceuticals N/A N/A N/A

In the previous week, 60 Degrees Pharmaceuticals and 60 Degrees Pharmaceuticals both had 1 articles in the media. 60 Degrees Pharmaceuticals' average media sentiment score of 0.00 equaled Conduit Pharmaceuticals'average media sentiment score.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
60 Degrees Pharmaceuticals
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Conduit Pharmaceuticals
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A
Conduit PharmaceuticalsN/AN/AN/AN/AN/A

Summary

60 Degrees Pharmaceuticals beats Conduit Pharmaceuticals on 1 of the 1 factors compared between the two stocks.

How does Conduit Pharmaceuticals compare to Alpha Tau Medical?

Conduit Pharmaceuticals (NASDAQ:CDTTW) and Alpha Tau Medical (NASDAQ:DRTSW) are both medical companies, but which is the superior stock? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, institutional ownership, dividends, risk, valuation and profitability.

Company Net Margins Return on Equity Return on Assets
Conduit PharmaceuticalsN/A N/A N/A
Alpha Tau Medical N/A N/A N/A

In the previous week, Alpha Tau Medical had 2 more articles in the media than Conduit Pharmaceuticals. MarketBeat recorded 3 mentions for Alpha Tau Medical and 1 mentions for Conduit Pharmaceuticals. Alpha Tau Medical's average media sentiment score of 0.37 beat Conduit Pharmaceuticals' score of 0.00 indicating that Alpha Tau Medical is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Conduit Pharmaceuticals
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Alpha Tau Medical
1 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Conduit PharmaceuticalsN/AN/AN/AN/AN/A
Alpha Tau MedicalN/AN/AN/AN/AN/A

Summary

Alpha Tau Medical beats Conduit Pharmaceuticals on 2 of the 2 factors compared between the two stocks.

How does Conduit Pharmaceuticals compare to Apollomics?

Conduit Pharmaceuticals (NASDAQ:CDTTW) and Apollomics (NASDAQ:APLMW) are both medical companies, but which is the superior investment? We will compare the two companies based on the strength of their profitability, analyst recommendations, risk, media sentiment, institutional ownership, dividends, valuation and earnings.

Company Net Margins Return on Equity Return on Assets
Conduit PharmaceuticalsN/A N/A N/A
Apollomics N/A N/A N/A

In the previous week, Conduit Pharmaceuticals had 1 more articles in the media than Apollomics. MarketBeat recorded 1 mentions for Conduit Pharmaceuticals and 0 mentions for Apollomics. Conduit Pharmaceuticals' average media sentiment score of 0.00 equaled Apollomics'average media sentiment score.

Company Overall Sentiment
Conduit Pharmaceuticals Neutral
Apollomics Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Conduit PharmaceuticalsN/AN/AN/AN/AN/A
Apollomics$8.50MN/AN/AN/AN/A

Summary

Conduit Pharmaceuticals and Apollomics tied by winning 1 of the 2 factors compared between the two stocks.

How does Conduit Pharmaceuticals compare to BioVie?

Conduit Pharmaceuticals (NASDAQ:CDTTW) and BioVie (NASDAQ:BIVIW) are both medical companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, media sentiment, valuation and profitability.

Company Net Margins Return on Equity Return on Assets
Conduit PharmaceuticalsN/A N/A N/A
BioVie N/A N/A N/A

In the previous week, BioVie had 1 more articles in the media than Conduit Pharmaceuticals. MarketBeat recorded 2 mentions for BioVie and 1 mentions for Conduit Pharmaceuticals. BioVie's average media sentiment score of 0.37 beat Conduit Pharmaceuticals' score of 0.00 indicating that BioVie is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Conduit Pharmaceuticals
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
BioVie
0 Very Positive mention(s)
1 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Conduit PharmaceuticalsN/AN/AN/AN/AN/A
BioVieN/AN/AN/AN/AN/A

Summary

BioVie beats Conduit Pharmaceuticals on 2 of the 2 factors compared between the two stocks.

How does Conduit Pharmaceuticals compare to Cardio Diagnostics?

Cardio Diagnostics (NASDAQ:CDIOW) and Conduit Pharmaceuticals (NASDAQ:CDTTW) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their media sentiment, valuation, profitability, dividends, analyst recommendations, earnings, institutional ownership and risk.

Company Net Margins Return on Equity Return on Assets
Cardio DiagnosticsN/A N/A N/A
Conduit Pharmaceuticals N/A N/A N/A

In the previous week, Conduit Pharmaceuticals had 1 more articles in the media than Cardio Diagnostics. MarketBeat recorded 1 mentions for Conduit Pharmaceuticals and 0 mentions for Cardio Diagnostics. Cardio Diagnostics' average media sentiment score of 0.00 equaled Conduit Pharmaceuticals'average media sentiment score.

Company Overall Sentiment
Cardio Diagnostics Neutral
Conduit Pharmaceuticals Neutral

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Cardio Diagnostics$16.57KN/AN/AN/AN/A
Conduit PharmaceuticalsN/AN/AN/AN/AN/A

Summary

Cardio Diagnostics and Conduit Pharmaceuticals tied by winning 1 of the 2 factors compared between the two stocks.

Get Conduit Pharmaceuticals News Delivered to You Automatically

Sign up to receive the latest news and ratings for CDTTW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding CDTTW and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

CDTTW vs. The Competition

MetricConduit PharmaceuticalsBiotechnology IndustryMedical SectorNASDAQ Exchange
Market CapN/A$528.46M$7.01B$12.68B
Dividend YieldN/A3.90%2.67%9.42%
P/E RatioN/A3.4926.8823.95
Price / SalesN/A6,282.29574.12115.11
Price / CashN/A13.1350.6060.45
Price / BookN/A87.6810.566.16
Net IncomeN/A-$96.07M$3.60B$331.73M
7 Day PerformanceN/A-0.12%-1.35%-0.92%
1 Month PerformanceN/A-0.48%-0.30%-2.23%
1 Year PerformanceN/A56.41%18.98%14.79%

Conduit Pharmaceuticals Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
CDTTW
Conduit Pharmaceuticals
N/A$0.01
-26.7%
N/A+37.5%$0.00N/AN/A7
SXTPW
60 Degrees Pharmaceuticals
N/A$0.03
+8.8%
N/A-61.5%$0.00$1.00MN/A2
DRTSW
Alpha Tau Medical
N/A$3.68
-3.4%
N/A+1,286.6%$0.00N/AN/A80
APLMW
Apollomics
N/A$0.02
+54.2%
N/A-41.5%$0.00$8.50MN/A59
BIVIW
BioVie
N/A$0.43
flat
N/AN/A$0.00N/AN/AN/A

Related Companies and Tools


This page (NASDAQ:CDTTW) was last updated on 7/23/2026 by MarketBeat.com Staff.
From Our Partners